BIOL 5200 Glycobiology and Human Disease

Satisfies the advanced experience requirement for the Biology major. In this seminar course we will discuss the structures, function, and metabolism (biosynthesis and degradation) of carbohydrate-containing molecules, which are widely distributed in nature. Glycosylation is a major type of posttranslational modification of proteins and lipids, and as a result of such modification these molecules (glycoconjugates) obtained new physical, chemical and biological properties that frequently determine very specific processes in the cells and whole living organisms. Glycoconjugates have important roles in intercellular interactions and adhesion, signaling, the immune response, fertilization, embryogenesis, the action of hormones and receptors, etc. Disorders (often hereditary) in degradation and biosynthesis of glycoconjugates lead to development of very severe diseases, a variety of lysosomal storage diseases (LSD) and congenital disorders of glycosylation (CDG), respectively. For the past two decades, new fields of study termed glycomedicine and glycopharmacology have been developing rapidly.

Course overview

Department
Biology
School
MCAS
Credits
2
Level
Both
Offered
Annually

Catalog details

Prerequisites
BIOL2000 and BIOL2040 and BIOL3040 or BIOL4350 or CHEM4461 or CHEM2242

Catalog text is imported from the reviewed Boston College course snapshot. Confirm eligibility in EagleApps.

Requirements fulfilled

No source-backed degree requirement is attached to this course yet.

Official evaluation summary

3.80 / 5

Based on 15 aggregate responses from BC Avalanche/Blue evaluations.

Data freshness

Course and evaluation data last updated 2026-08-02. Source details and limitations are documented in Data Sources and Methodology.

Instructors

  • Gherman Wiederschain
    Fall 2026, Fall 2025, Fall 2024 · Official rating 4.27/5

Sections

  • Section 01
    Fall 2026 · Gherman Wiederschain · Higgins Hall 260 MW 09:00AM-09:50AM · Offered